APPLICATION OF MELANOTROPINSTIMULATING FACTOR AS A THERAPEUTIC MEDICINE

摘要

1. The use of the Lys-Lys-Gly-Glu-OH peptide for the manufacture of a pharmaceutical composition for the treatment and / or prophylaxis of a malignant tumor, autoimmune diseases, fibrosis, inflammatory diseases, infectious diseases, lung diseases, heart and blood vessel diseases and metabolic diseases. ! 2. The use of the peptide according to claim 1, where the malignant tumor, autoimmune disease, fibrosis, inflammatory disease, infectious disease, lung disease, heart and vascular disease or metabolic disease are selected from shock and tissue damage, vascular permeability syndrome, acute respiratory distress - syndrome, gastrointestinal necrosis, acute renal tubule necrosis, adrenal hemorrhage, anorexia, hepatosplenomegaly, subendocardial inflammation, insulin resistance, l pulmonary hypertension, sarcoidosis, pulmonary fibrosis and / or COPD. ! 3. The use of the peptide according to claim 1 or 2 to obtain a composition for oral administration to newborns, toddlers and / or preschool children. ! 4. The use of the peptide according to claim 1 or 2 to obtain a lyophilized composition or a buffer liquid composition. ! 5. A pharmaceutical composition comprising a Lys-Lys-Gly-Glu-OH peptide in association with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotector, excipient and / or diluent. ! 6. The pharmaceutical composition according to claim 5 in the form of a lyophilisate or a liquid buffer solution. ! 7. The pharmaceutical composition according to claim 5 or 6, suitable for intravenous administration, oral administration or for administration by inhalation. ! 8. Pharmaceutical Compound